October 26, 20 - 9:23 am - LABS

AstraZeneca’s vaccine has a robust immune response on elderly: FT

The Financial Times reported this Monday that the vaccine developed by the University of Oxford and the pharmaceutical firm AstraZeneca has produced a robust immune response in elderly people, the most vulnerable group to COVID-19, according to two people familiar with the finding. The immunizer is in the final stages of trials. The Brazilian government has a partnership to have the AstraZeneca’s vaccine, as the country already ordered 100 million doses.